Fig. 3
From: Pharmacomicrobiomics: exploiting the drug-microbiota interactions in anticancer therapies

“Biotic” strategies to modulate microbiota and the outcome of anticancer therapies
From: Pharmacomicrobiomics: exploiting the drug-microbiota interactions in anticancer therapies
“Biotic” strategies to modulate microbiota and the outcome of anticancer therapies